Analysis of factors driving HPV vaccination coverage and associated cost savings in the united States.

ABSTRACT:

Background

Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States (U.S.) and has a significant healthcare burden and cost due to HPV-related cancers and diseases. Despite the proven safety and effectiveness of the HPV vaccine, its uptake in the U.S remains suboptimal. Furthermore, the combined influence of individual, social, and policy factors on HPV vaccination rates remains unclear. This study investigated how individual, social, and policy factors affect HPV vaccination rates, focusing on initiation and completion rates in the U.S. It also aimed to assess the potential cost savings from implementing certain recommended policy changes, aiming to boost HPV vaccination rates and subsequently lower HPV-related cancer cases.

Methods

SUBMITTER: Wang S 

PROVIDER: S-EPMC12363118 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature